Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$785M Buy
27,941,976
+681,917
+3% +$18.2M 0.08% 216
2025
Q4
$679M Sell
27,260,059
-3,075,783
-10% -$77.6M 0.06% 238
2025
Q3
$773M Buy
30,335,842
+1,085,701
+4% +$26.8M 0.12% 177
2025
Q2
$709M Sell
29,250,141
-1,046,196
-3% -$24.4M 0.12% 182
2025
Q1
$768M Buy
30,296,337
+838,198
+3% +$21.9M 0.15% 150
2024
Q4
$782M Buy
29,458,139
+2,579,455
+10% +$70M 0.14% 144
2024
Q3
$778M Buy
26,878,684
+105,267
+0.4% +$3.07M 0.15% 142
2024
Q2
$749M Sell
26,773,417
-2,551,918
-9% -$70.3M 0.16% 124
2024
Q1
$814M Buy
29,325,335
+5,199,072
+22% +$144M 0.17% 114
2023
Q4
$695M Buy
24,126,263
+71,367
+0.3% +$2.16M 0.17% 126
2023
Q3
$798M Buy
24,054,896
+5,678,004
+31% +$201M 0.21% 82
2023
Q2
$674M Buy
18,376,892
+1,384,267
+8% +$53.9M 0.18% 116
2023
Q1
$693M Buy
16,992,625
+914,358
+6% +$39.5M 0.19% 105
2022
Q4
$824M Buy
16,078,267
+522,447
+3% +$25M 0.24% 70
2022
Q3
$681M Buy
15,555,820
+2,484,509
+19% +$121M 0.22% 82
2022
Q2
$685M Sell
13,071,311
-3,579,592
-21% -$182M 0.21% 89
2022
Q1
$862M Sell
16,650,903
-3,285,874
-16% -$170M 0.22% 82
2021
Q4
$1.18B Sell
19,936,777
-498,860
-2% -$24.7M 0.28% 53
2021
Q3
$879M Sell
20,435,637
-532,523
-3% -$23.6M 0.22% 83
2021
Q2
$821M Buy
20,968,160
+3,077,632
+17% +$120M 0.2% 93
2021
Q1
$648M Buy
17,890,528
+1,138,391
+7% +$40.4M 0.17% 131
2020
Q4
$617M Sell
16,752,137
-2,749,057
-14% -$101M 0.18% 120
2020
Q3
$679M Sell
19,501,194
-1,076,384
-5% -$37.7M 0.23% 81
2020
Q2
$638M Sell
20,577,578
-1,239,071
-6% -$42.1M 0.23% 86
2020
Q1
$676M Buy
21,816,649
+2,817,445
+15% +$96M 0.28% 70
2019
Q4
$706M Sell
18,999,204
-2,348,941
-11% -$83.7M 0.22% 97
2019
Q3
$728M Sell
21,348,145
-910,866
-4% -$33.1M 0.19% 106
2019
Q2
$915M Buy
22,259,011
+2,838,790
+15% +$113M 0.24% 74
2019
Q1
$783M Sell
19,420,221
-6,550,676
-25% -$262M 0.26% 74
2018
Q4
$1.08B Sell
25,970,897
-3,374,103
-11% -$140M 0.41% 32
2018
Q3
$1.23B Sell
29,345,000
-9,784,932
-25% -$377M 0.39% 37
2018
Q2
$1.35B Sell
39,129,932
-1,917,142
-5% -$65.5M 0.45% 25
2018
Q1
$1.38B Sell
41,047,074
-608,446
-1% -$20.9M 0.52% 18
2017
Q4
$1.43B Buy
41,655,520
+270,941
+0.7% +$9.24M 0.52% 19
2017
Q3
$1.4B Sell
41,384,579
-1,426,527
-3% -$45.8M 0.52% 21
2017
Q2
$1.36B Sell
42,811,106
-1,652,376
-4% -$52.1M 0.42% 34
2017
Q1
$1.44B Sell
44,463,482
-1,868,653
-4% -$58.9M 0.47% 30
2016
Q4
$1.43B Sell
46,332,135
-1,194,646
-3% -$36.5M 0.48% 32
2016
Q3
$1.53B Buy
47,526,781
+2,244,805
+5% +$75.1M 0.52% 26
2016
Q2
$1.51B Sell
45,281,976
-3,715,505
-8% -$119M 0.56% 23
2016
Q1
$1.38B Buy
48,997,481
+7,782,156
+19% +$222M 0.56% 20
2015
Q4
$1.26B Sell
41,215,325
-6,348,479
-13% -$200M 0.5% 26
2015
Q3
$1.42B Sell
47,563,804
-1,702,992
-3% -$54.6M 0.6% 20
2015
Q2
$1.57B Buy
49,266,796
+2,189,532
+5% +$71.4M 0.62% 18
2015
Q1
$1.55B Sell
47,077,264
-3,365,402
-7% -$107M 0.6% 18
2014
Q4
$1.49B Sell
50,442,666
-26,028
-0.1% -$746K 0.58% 20
2014
Q3
$1.42B Sell
50,468,694
-3,414,168
-6% -$95.8M 0.57% 21
2014
Q2
$1.52B Sell
53,882,862
-10,884,034
-17% -$310M 0.6% 19
2014
Q1
$1.97B Buy
64,766,896
+3,841,888
+6% +$115M 0.8% 13
2013
Q4
$1.77B Sell
60,925,008
-872,489
-1% -$25.4M 0.7% 18
2013
Q3
$1.68B Sell
61,797,497
-1,566,806
-2% -$42.6M 0.73% 16
2013
Q2
$1.68B Buy
+63,364,303
New +$1.75B 0.79% 13

Other funds holding PFE

Invesco's PFE Position: Q1 2026 in Review

Invesco increased its Pfizer (PFE) stake by 2.5% in Q1 2026, buying an estimated $18.2M and bringing the position to 27,941,976 shares worth $785M. The position accounts for 0.08% of the portfolio, ranked #216.

Invesco first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.97B in Q1 2014. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Invesco held 27,941,976 shares of Pfizer worth $785M as of Q1 2026.
  • Invesco bought 681,917 Pfizer shares in Q1 2026, an estimated $18.2M.
  • Pfizer made up 0.08% of Invesco's portfolio in Q1 2026, its #216 holding.
  • Invesco first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Invesco's Pfizer position peaked at $1.97B in Q1 2014.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.